A longitudinal analysis of HIV treatment adherence among men who have sex with men: a cognitive escape perspective

AIDS Care. 2012;24(11):1425-31. doi: 10.1080/09540121.2011.650676. Epub 2012 Jan 31.

Abstract

HIV is best managed by adhering to both medication and HIV care appointment schedules. Nonetheless, many HIV-positive men who have sex with men (MSM) report low levels of adherence to both. To explain this, we tested a cognitive escape model whereby drug and alcohol use mediate the effects of depression on HIV medication and appointment adherence. We used longitudinal data (n=856) from a behavioral intervention promoting increased treatment adherence among HIV-positive MSM. All model variables predicted appointment adherence, and our mediation hypotheses were supported. Conversely, although depression related to medication adherence, substance use did not mediate this relationship, as predicted. Self-reported appointment, but not medication, adherence related to changes in viral load over time. Therefore, cognitive escape characterizes appointment, but not medication, adherence within this sample. Future behavioral interventions for this population should target HIV appointment adherence, given its relationship to important clinical, psychological, and behavioral outcomes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Chicago
  • Cognition
  • Depression / diagnosis
  • Depression / psychology*
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • Homosexuality, Male* / psychology
  • Humans
  • Interviews as Topic
  • Logistic Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Models, Psychological
  • Patient Compliance / psychology*
  • Patient Compliance / statistics & numerical data
  • Primary Health Care / statistics & numerical data*
  • Risk Factors
  • Socioeconomic Factors
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / psychology*
  • Viral Load
  • Young Adult

Substances

  • Anti-HIV Agents